Trial Profile
Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Eszopiclone (Primary)
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- 26 Oct 2016 Status changed from recruiting to completed.
- 20 Jan 2009 New trial record.